Cargando…
Worsening of Cardiomyopathy Using Deflazacort in an Animal Model Rescued by Gene Therapy
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in the delta-sarcoglycan deficient cardiomyopathic hamster. In patients with similar genetic defects, steroids have been largely used to slow down disease progression. Aim of our study was to evaluate the...
Autores principales: | Rotundo, Ida Luisa, Faraso, Stefania, De Leonibus, Elvira, Nigro, Gerardo, Vitiello, Carmen, Lancioni, Alessio, Di Napoli, Daniele, Castaldo, Sigismondo, Russo, Vincenzo, Russo, Fabio, Piluso, Giulio, Auricchio, Alberto, Nigro, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170375/ https://www.ncbi.nlm.nih.gov/pubmed/21931833 http://dx.doi.org/10.1371/journal.pone.0024729 |
Ejemplares similares
-
Disease Rescue and Increased Lifespan in a Model of Cardiomyopathy and Muscular Dystrophy by Combined AAV Treatments
por: Vitiello, Carmen, et al.
Publicado: (2009) -
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex
por: Lancioni, Alessio, et al.
Publicado: (2011) -
The role of P-wave dispersion in dystrophic and thalassemic cardiomyopathy
por: Russo, Vincenzo, et al.
Publicado: (2017) -
Next generation sequencing (NGS) strategies
for the genetic testing of myopathies
por: NIGRO, VINCENZO, et al.
Publicado: (2012) -
Polycystic ovary syndrome and arrhythmic risk: the role of comorbidities and the prevalence of interatrial block
por: Russo, Vincenzo, et al.
Publicado: (2016)